72305-24-9

Upstream product

• 32315-10-9 bis(trichloromethyl) carbonate 
• 95-77-2 3,4-dichlorophenol 
• 76-02-8 trifluoroacetyl chloride 

Downstream Products

• 72304-73-5 dimethyl 3,4-dichlorophenoxycarbonylphosphonate 
• 1186532-44-4 3,9-diaza-bicyclo[3.3.1]nonane-3-carboxylic acid 3,4-dichloro-phenyl ester hydrochloric acid salt 
• 1186532-36-4 9-methyl-3,9-diaza-bicyclo[3.3.1]nonane-3-carboxylic acid 3,4-dichloro-phenyl ester 
• 894798-54-0 3,4-dichlorophenyl 4-[(1-methylpiperidin-3-yl)methyl]piperazine-1-carboxylate 
• 74270-34-1 C₇H₃Cl₂O₅P^(2-)*2Na⁽¹⁺⁾ 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS AS CCR2B ANTAGONISTS

Compounds of formula (I) Q-L-W-C(=X)-Z-P wherein Q is an amine of the formula-N (R1)(R2); L is an alkyl or heterocyclyl-alkyl linker; W is a 6-or 7-membered aliphatic ring comprising ring atoms Y1 and Y2 which are linked to groups L and C(X) respectively and Y1 and Y2 are independently selected from N and C; X is O, N, N-CN or S; Z is NR 3; P is an optionally substituted monocyclic or bicyclic aryl or heteroaryl group; and pharmaceutically acceptable salts or solvates thereof, are useful in the treatment of C-C chemokine mediated conditions.

Synthesis of 5-membered ring-type compounds as potential cholecystokinin receptor ligands

Imidazolidine-2,4-diones and 1,5-diphenyl tetrainic acid derivatives were selected in order to evaluate some 5-membered heterocyclic ring compounds as potential templates for the synthesis of CCK receptor ligands. All the compounds were evaluated in vitro towards both CCK-B and CCK-A receptors.